Prefilled Syringes Changing the Injectable Drug Delivery Landscape

Greystone Associates Analyzes Demand Factors and Market Dynamics Driving Growth

[USPRwire, Tue Mar 30 2010] As technical issues such as materials performance, storage stability and lubricity have fallen by the wayside, prefilled syringes have come to the forefront in the battle for injectable device market share. The broad acceptance of prefilled syringes across caregiver sectors and therapeutic segments, combined with improved patient safety and compliance, are among the key factors driving the unit growth of these devices. Many providers continue to express a preference for prefilled syringes over vials, particularly for vaccines, noting the prefilled syringes save staff preparation and documentation time and increase accuracy and safety. As the number of therapeutic drugs being packaged in prefilled syringes continues to grow, the trend is having an irreversible effect on the behavior and expectations of end users.

For prefilled syringe manufacturers and Fill-and-Finish contractors, market proximity is an important competitive factor, and the past twelve months have seen major prefilled syringe suppliers and CMOs expanding their operations in regional markets, particularly in North America. Vetter’s new Chicago facility and Unilife’s corporate relocation to Pennsylvania are two indications of the rising stakes in the competition for the North American prefilled syringe market.

As the use of prefilled syringes continues to grow, the issue of prefilled syringe safety has received increased attention, with both integrated prefillable safety syringes and safety solutions designed to accommodate existing prefillable syringes advancing commercially. The majority of new prefilled syringe products introduced in North America, where sharps legislation has been in place since 2000, now include a sharps safety feature or capability.

More information on the growth of prefilled syringes can be found in a comprehensive report, researched and prepared by Greystone Associates. Prefilled Syringes: Market Evolution, Product Strategies and Therapeutic Opportunities examines prefilled syringe market segments and product data, analyzes eleven important prefilled syringe therapeutic segments and examines key regulatory, economic and competitive factors that represent potential barriers to commercial success.

More information is available at www.greystoneassociates.org .

About Greystone

Greystone Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.

Contact:

Mark Smith
Voice: 603-595-4340
Fax: 603-804-0466
www.greystoneassociates.org
Source: Greystone Associates